Bank of New York Mellon’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
301,959
+224,257
| +289% | +$10.9M | ﹤0.01% | 1680 |
|
|
2025
Q1 | $2.64M | Buy |
77,702
+1,133
| +1% | +$38.6K | ﹤0.01% | 2544 |
|
|
2024
Q4 | $3.01M | Buy |
76,569
+1,553
| +2% | +$61.1K | ﹤0.01% | 2555 |
|
|
2024
Q3 | $3.52M | Sell |
75,016
-3,676
| -5% | -$173K | ﹤0.01% | 2466 |
|
|
2024
Q2 | $4.25M | Buy |
78,692
+3,378
| +4% | +$182K | ﹤0.01% | 2410 |
|
|
2024
Q1 | $5.13M | Sell |
75,314
-32,579
| -30% | -$2.22M | ﹤0.01% | 2316 |
|
|
2023
Q4 | $6.75M | Buy |
107,893
+2,478
| +2% | +$155K | ﹤0.01% | 2218 |
|
|
2023
Q3 | $4.78M | Sell |
105,415
-2,670
| -2% | -$121K | ﹤0.01% | 2343 |
|
|
2023
Q2 | $6.07M | Sell |
108,085
-772
| -0.7% | -$43.3K | ﹤0.01% | 2215 |
|
|
2023
Q1 | $4.92M | Sell |
108,857
-50
| -0% | -$2.26K | ﹤0.01% | 2303 |
|
|
2022
Q4 | $4.43M | Sell |
108,907
-9,537
| -8% | -$388K | ﹤0.01% | 2408 |
|
|
2022
Q3 | $7.74M | Buy |
118,444
+16,669
| +16% | +$1.09M | ﹤0.01% | 2054 |
|
|
2022
Q2 | $6.19M | Buy |
101,775
+10,713
| +12% | +$651K | ﹤0.01% | 2206 |
|
|
2022
Q1 | $5.72M | Buy |
91,062
+26,358
| +41% | +$1.65M | ﹤0.01% | 2346 |
|
|
2021
Q4 | $4.9M | Buy |
64,704
+2,636
| +4% | +$200K | ﹤0.01% | 2474 |
|
|
2021
Q3 | $6.95M | Buy |
62,068
+762
| +1% | +$85.3K | ﹤0.01% | 2324 |
|
|
2021
Q2 | $9.93M | Buy |
61,306
+16,369
| +36% | +$2.65M | ﹤0.01% | 2135 |
|
|
2021
Q1 | $5.48M | Buy |
44,937
+5,090
| +13% | +$620K | ﹤0.01% | 2411 |
|
|
2020
Q4 | $6.1M | Sell |
39,847
-200,056
| -83% | -$30.6M | ﹤0.01% | 2262 |
|
|
2020
Q3 | $20.1M | Buy |
239,903
+16,118
| +7% | +$1.35M | 0.01% | 1474 |
|
|
2020
Q2 | $16.4M | Buy |
223,785
+14,354
| +7% | +$1.05M | ﹤0.01% | 1565 |
|
|
2020
Q1 | $8.88M | Buy |
209,431
+163,264
| +354% | +$6.92M | ﹤0.01% | 1761 |
|
|
2019
Q4 | $2.81M | Buy |
46,167
+6,736
| +17% | +$410K | ﹤0.01% | 2620 |
|
|
2019
Q3 | $1.62M | Buy |
39,431
+6,340
| +19% | +$260K | ﹤0.01% | 2869 |
|
|
2019
Q2 | $1.56M | Buy |
33,091
+17,810
| +117% | +$839K | ﹤0.01% | 2948 |
|
|
2019
Q1 | $546K | Sell |
15,281
-1,970
| -11% | -$70.4K | ﹤0.01% | 3506 |
|
|
2018
Q4 | $493K | Sell |
17,251
-17,367
| -50% | -$496K | ﹤0.01% | 3487 |
|
|
2018
Q3 | $1.54M | Buy |
34,618
+3,514
| +11% | +$156K | ﹤0.01% | 3005 |
|
|
2018
Q2 | $1.83M | Buy |
31,104
+9,326
| +43% | +$548K | ﹤0.01% | 2898 |
|
|
2018
Q1 | $995K | Buy |
+21,778
| New | +$995K | ﹤0.01% | 3221 |
|
|
2017
Q4 | – | Sell |
-16,132
| Closed | -$288K | – | 4348 |
|
|
2017
Q3 | $288K | Buy |
+16,132
| New | +$288K | ﹤0.01% | 3769 |
|